España
Acceder
Cotización de Apellis Pharmaceuticals, Inc. (APLS) hoy en tiempo real
Análisis técnico y gráfico histórico de Apellis Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Apellis Pharmaceuticals, Inc.
Ficha de Apellis Pharmaceuticals, Inc. (APLS)
| Ticker | APLS |
|---|---|
| ISIN | US03753U1060 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Apellis Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Apellis Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Apellis Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Apellis Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Apellis Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Apellis Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Apellis Pharmaceuticals, Inc.
Invertir en Apellis Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases. It also develops...
¿En qué sector opera Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.